Insider · CIK 0001241353

YUM SU IL

Reports to the SEC for 1 company · CUPERTINO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001241353

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-01-09	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+64.5K sh	—	—	64,452
2015-01-09	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+70.5K sh	—	—	70,512
2015-01-09	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+15.5K sh	—	—	86,060
2014-01-31	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+59.6K sh	—	—	59,620
2014-01-31	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+30.4K sh	—	—	30,380
2014-01-31	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+52K sh	—	—	82,422
2013-02-05	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+56.3K sh	—	—	56,250
2013-02-05	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+43.8K sh	—	—	43,750
2013-02-05	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+40.9K sh	—	—	84,661
2013-02-05	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+67K sh	—	—	151,659
2012-10-17	DURECT CORPM Exercise/Conversion	Exec. VP Pharm./R&D	MExercise/Conversion	+14.4K sh	$0.78	+$11.2K	14,374
2012-10-17	DURECT CORPM Exercise/Conversion	Exec. VP Pharm./R&D	MExercise/Conversion	+28K sh	$0.78	+$21.8K	42,378
2012-10-17	DURECT CORPM Exercise/Conversion	Exec. VP Pharm./R&D	MExercise/Conversion	+31.1K sh	$0.78	+$24.2K	73,454
2012-10-17	DURECT CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Exec. VP Pharm./R&D	MExercise/Conversion	−14.4K sh	—	—	154,844
2012-10-17	DURECT CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Exec. VP Pharm./R&D	MExercise/Conversion	−28K sh	—	—	126,840
2012-10-17	DURECT CORPNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Exec. VP Pharm./R&D	MExercise/Conversion	−31.1K sh	—	—	95,764
2012-02-03	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+35.9K sh	—	—	35,939
2012-02-03	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+62.2K sh	—	—	62,153
2012-02-03	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+28K sh	—	—	90,157
2012-02-03	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+79.1K sh	—	—	169,218
2011-01-20	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+34.2K sh	—	—	34,200
2011-01-20	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+106K sh	—	—	105,800
2010-01-22	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+32.3K sh	—	—	32,333
2010-01-22	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+39K sh	—	—	39,029
2010-01-22	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+92.7K sh	—	—	131,696
2009-05-21	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+9,252 sh	—	—	9,252
2009-05-21	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+64.7K sh	—	—	64,748
2009-01-27	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+8,751 sh	—	—	8,751
2009-01-27	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+131K sh	—	—	131,249
2008-01-18	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+17K sh	—	—	16,977
2008-01-18	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+93K sh	—	—	93,023
2006-01-06	DURECT CORPIncentive Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+34.7K sh	—	—	34,746
2006-01-06	DURECT CORPNon-Qualified Stock Option (right to buy)A Award	Exec. VP Pharm./R&D	AAward	+85.3K sh	—	—	85,254
2004-12-17	DURECT CORPIncentive Stock Option (Right to Buy)A Award	Exec. VP Pharm./R&D	AAward	+9,002 sh	—	—	9,002
2004-12-17	DURECT CORPNon-Qualified Stock Option (Right to Buy)A Award	Exec. VP Pharm./R&D	AAward	+91K sh	—	—	90,998

Recent filings

Accepted (ET)
Jan 134
DURECT CORP0001082038-15-000004
SEC(opens sec.gov)
Feb 44
DURECT CORP0001082038-14-000004
SEC(opens sec.gov)
Feb 74
YUM SU IL0001082038-13-000005
SEC(opens sec.gov)
Oct 184
YUM SU IL0001082038-12-000025
SEC(opens sec.gov)
Feb 74
YUM SU IL0001082038-12-000006
SEC(opens sec.gov)

Companies

DURECT CORPExec. VP Pharm./R&D

Address

2 RESULTS WAY

CUPERTINO, CA, 95014